India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Suven Life Sciences Ltd.

Income Statement - Consolidated

Market Cap.(`)	4618.15 Cr.	P/BV	23.97	Book Value (`)	8.84
52 Week High/Low ( ` )	218/83	FV/ML	1/1	P/E(X)	0.00
Book Closure	02/08/2024	EPS (`)	0.00	Div Yield (%)	0.00

(` in Crs.)

You can view the Consolidated Income Statement for the last 5 years.

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00


INCOME
Revenue From Operations [Net]	6.66	11.69	13.54	11.84	13.48
Total Operating Revenues	6.66	11.69	13.54	11.84	13.48

Other Income	10.90	21.13	8.45	5.32	7.75
Total Revenue	17.55	32.82	21.99	17.16	21.23

EXPENSES
Employee Benefit Expenses	20.82	18.99	18.62	21.02	18.53
Finance Costs	0.05	0.16	0.29	0.53	0.82
Depreciation And Amortisation Expenses	5.82	6.50	6.54	4.39	4.35
Other Expenses	151.60	120.71	120.80	113.21	75.02
Total Expenses	178.30	146.36	146.26	139.16	98.71

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	-160.75	-113.54	-124.27	-122.00	-77.47

Exceptional Items	0.00	7.46	6.00	0.00	0.00
Profit/Loss Before Tax	-160.75	-106.08	-118.27	-122.00	-77.47

Tax Expenses-Continued Operations
Deferred Tax	0.00	0.00	0.00	0.00	-5.70
Tax For Earlier Years	0.00	-1.00	0.00	0.00	0.38
Total Tax Expenses	0.00	-1.00	0.00	0.00	-5.32
Profit/Loss After Tax And Before ExtraOrdinary Items	-160.75	-105.08	-118.27	-122.00	-72.15

Profit/Loss From Continuing Operations	-160.75	-105.08	-118.27	-122.00	-72.15

Profit/Loss For The Period	-160.75	-105.08	-118.27	-122.00	-72.15
Consolidated Profit/Loss After MI And Associates	-160.75	-105.08	-118.27	-122.00	-72.15

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	-7.37	-4.82	-6.63	-9.57	-5.67
Diluted EPS (Rs.)	-7.37	-4.82	-6.63	-9.57	-5.67

Suven Life Sciences Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	4618.15 Cr.	P/BV	23.97	Book Value (`)	8.84
52 Week High/Low ( ` )	218/83	FV/ML	1/1	P/E(X)	0.00
Book Closure	02/08/2024	EPS (`)	0.00	Div Yield (%)	0.00

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00
No. of Equity Shares (in Lacs)	2180.74	2180.74	2180.74	1453.82	1272.82

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	21.81	21.81	21.81	14.54	12.73
Total Share Capital	21.81	21.81	21.81	14.54	12.73

Reserves and Surplus	88.18	248.23	353.51	81.61	58.36
Total Reserves and Surplus	88.18	248.23	353.51	81.61	58.36
Money Received Against Share Warrants	0.00	0.00	0.00	0.00	36.92
Total Shareholders Funds	109.99	270.04	375.32	96.15	108.01

NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	0.00	0.39
Other Long Term Liabilities	0.00	0.00	0.58	1.57	2.38
Long Term Provisions	1.71	1.35	1.88	2.00	1.73
Total Non-Current Liabilities	1.71	1.35	2.46	3.57	4.50

CURRENT LIABILITIES
Short Term Borrowings	0.00	0.00	0.00	0.48	0.00
Trade Payables	5.23	2.07	1.66	1.99	3.00
Other Current Liabilities	16.62	10.33	8.44	4.96	12.13
Short Term Provisions	1.64	1.12	1.03	0.89	0.78
Total Current Liabilities	23.49	13.52	11.13	8.31	15.91

Total Capital And Liabilities	135.18	284.90	388.91	108.03	128.42

ASSETS
NON-CURRENT ASSETS
Tangible Assets	59.47	28.01	37.02	37.34	20.83
Intangible Assets	0.18	0.20	0.20	0.22	0.14
Capital Work-In-Progress	0.01	0.00	0.00	3.55	4.77
Fixed Assets	59.66	28.21	37.21	41.12	25.74
Other Non-Current Assets	0.05	0.02	100.11	0.33	0.00
Total Non-Current Assets	59.71	28.23	137.32	41.44	25.74


CURRENT ASSETS
Current Investments	22.28	75.94	46.34	45.16	0.09
Inventories	0.24	0.71	0.00	0.02	0.14
Trade Receivables	1.34	1.29	0.81	1.30	1.76
Cash And Cash Equivalents	37.73	163.98	184.28	5.52	46.65
Short Term Loans And Advances	0.00	0.00	0.00	0.00	41.45
OtherCurrentAssets	13.89	14.76	20.16	14.59	12.59
Total Current Assets	75.47	256.67	251.59	66.59	102.68

Total Assets	135.18	284.90	388.91	108.03	128.42

BONUS DETAILS
Bonus Equity Share Capital	0.00	5.76	5.76	5.76	5.76

CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.09
Current Investments Unquoted Book Value	0.00	75.94	46.34	45.16	0.00

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Suven Life Sciences Ltd.

Income Statement - Consolidated

Suven Life Sciences Ltd.

Balance Sheet - Consolidated